These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 32109419)
1. Opposite Modulation of RAC1 by Mutations in TRIO Is Associated with Distinct, Domain-Specific Neurodevelopmental Disorders. Barbosa S; Greville-Heygate S; Bonnet M; Godwin A; Fagotto-Kaufmann C; Kajava AV; Laouteouet D; Mawby R; Wai HA; Dingemans AJM; Hehir-Kwa J; Willems M; Capri Y; Mehta SG; Cox H; Goudie D; Vansenne F; Turnpenny P; Vincent M; Cogné B; Lesca G; Hertecant J; Rodriguez D; Keren B; Burglen L; Gérard M; Putoux A; ; Cantagrel V; Siquier-Pernet K; Rio M; Banka S; Sarkar A; Steeves M; Parker M; Clement E; Moutton S; Tran Mau-Them F; Piton A; de Vries BBA; Guille M; Debant A; Schmidt S; Baralle D Am J Hum Genet; 2020 Mar; 106(3):338-355. PubMed ID: 32109419 [TBL] [Abstract][Full Text] [Related]
2. More evidence on TRIO missense mutations in the spectrin repeat domain causing severe developmental delay and recognizable facial dysmorphism with macrocephaly. Kloth K; Graul-Neumann L; Hermann K; Johannsen J; Bierhals T; Kortüm F Neurogenetics; 2021 Jul; 22(3):221-224. PubMed ID: 34013494 [TBL] [Abstract][Full Text] [Related]
3. Neurodevelopmental disease-associated de novo mutations and rare sequence variants affect TRIO GDP/GTP exchange factor activity. Katrancha SM; Wu Y; Zhu M; Eipper BA; Koleske AJ; Mains RE Hum Mol Genet; 2017 Dec; 26(23):4728-4740. PubMed ID: 28973398 [TBL] [Abstract][Full Text] [Related]
4. Pathogenic TRIO variants associated with neurodevelopmental disorders perturb the molecular regulation of TRIO and axon pathfinding in vivo. Bonnet M; Roche F; Fagotto-Kaufmann C; Gazdagh G; Truong I; Comunale F; Barbosa S; Bonhomme M; Nafati N; Hunt D; Rodriguez MP; Chaudhry A; Shears D; Madruga M; Vansenne F; Curie A; Kajava AV; Baralle D; Fassier C; Debant A; Schmidt S Mol Psychiatry; 2023 Apr; 28(4):1527-1544. PubMed ID: 36717740 [TBL] [Abstract][Full Text] [Related]
5. The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin. Bellanger JM; Astier C; Sardet C; Ohta Y; Stossel TP; Debant A Nat Cell Biol; 2000 Dec; 2(12):888-92. PubMed ID: 11146652 [TBL] [Abstract][Full Text] [Related]
6. Identification of TRIO-GEFD1 chemical inhibitors using the yeast exchange assay. Blangy A; Bouquier N; Gauthier-Rouvière C; Schmidt S; Debant A; Leonetti JP; Fort P Biol Cell; 2006 Sep; 98(9):511-22. PubMed ID: 16686599 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative trio mutant. Debreceni B; Gao Y; Guo F; Zhu K; Jia B; Zheng Y J Biol Chem; 2004 Jan; 279(5):3777-86. PubMed ID: 14597635 [TBL] [Abstract][Full Text] [Related]
9. [Role of the multifunctional Trio protein in the control of the Rac1 and RhoA gtpase signaling pathways]. Bellanger JM; Zugasti O; Lazaro JB; Diriong S; Lamb N; Sardet C; Debant A C R Seances Soc Biol Fil; 1998; 192(2):367-74. PubMed ID: 9759378 [TBL] [Abstract][Full Text] [Related]
10. An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio. Sadybekov A; Tian C; Arnesano C; Katritch V; Herring BE Nat Commun; 2017 Sep; 8(1):601. PubMed ID: 28928363 [TBL] [Abstract][Full Text] [Related]
11. The Human Rho-GEF trio and its target GTPase RhoG are involved in the NGF pathway, leading to neurite outgrowth. Estrach S; Schmidt S; Diriong S; Penna A; Blangy A; Fort P; Debant A Curr Biol; 2002 Feb; 12(4):307-12. PubMed ID: 11864571 [TBL] [Abstract][Full Text] [Related]
12. Mutations specific to the Rac-GEF domain of Pengelly RJ; Greville-Heygate S; Schmidt S; Seaby EG; Jabalameli MR; Mehta SG; Parker MJ; Goudie D; Fagotto-Kaufmann C; Mercer C; ; Debant A; Ennis S; Baralle D J Med Genet; 2016 Nov; 53(11):735-742. PubMed ID: 27418539 [TBL] [Abstract][Full Text] [Related]
13. Detection of autism spectrum disorder-related pathogenic trio variants by a novel structure-based approach. Rao S; Sadybekov A; DeWitt DC; Lipka J; Katritch V; Herring BE Mol Autism; 2024 Apr; 15(1):12. PubMed ID: 38566250 [TBL] [Abstract][Full Text] [Related]
14. Distinct functions of Trio GEF domains in axon outgrowth of cerebellar granule neurons. Tao T; Sun J; Peng Y; Wang P; Chen X; Zhao W; Li Y; Wei L; Wang W; Zheng Y; Wang Y; Zhang X; Zhu MS J Genet Genomics; 2019 Feb; 46(2):87-96. PubMed ID: 30850274 [TBL] [Abstract][Full Text] [Related]
15. RAC1 Missense Mutations in Developmental Disorders with Diverse Phenotypes. Reijnders MRF; Ansor NM; Kousi M; Yue WW; Tan PL; Clarkson K; Clayton-Smith J; Corning K; Jones JR; Lam WWK; Mancini GMS; Marcelis C; Mohammed S; Pfundt R; Roifman M; Cohn R; Chitayat D; ; Millard TH; Katsanis N; Brunner HG; Banka S Am J Hum Genet; 2017 Sep; 101(3):466-477. PubMed ID: 28886345 [TBL] [Abstract][Full Text] [Related]
16. The DH and PH domains of Trio coordinately engage Rho GTPases for their efficient activation. Chhatriwala MK; Betts L; Worthylake DK; Sondek J J Mol Biol; 2007 May; 368(5):1307-20. PubMed ID: 17391702 [TBL] [Abstract][Full Text] [Related]
17. RNA analysis and computer-aided facial phenotyping help to classify a novel TRIO splice site variant. Schwartzmann S; Zhao M; Sczakiel HL; Hildebrand G; Ehmke N; Horn D; Mensah MA; Boschann F Am J Med Genet A; 2024 Jul; 194(7):e63599. PubMed ID: 38517182 [TBL] [Abstract][Full Text] [Related]
18. The N-terminal DH-PH domain of Trio induces cell spreading and migration by regulating lamellipodia dynamics in a Rac1-dependent fashion. van Rijssel J; Hoogenboezem M; Wester L; Hordijk PL; Van Buul JD PLoS One; 2012; 7(1):e29912. PubMed ID: 22238672 [TBL] [Abstract][Full Text] [Related]
19. Modeling human mutations to understand TRIO GEF function during development. Fingleton E; Roche KW Trends Neurosci; 2023 Jun; 46(6):411-412. PubMed ID: 36959051 [TBL] [Abstract][Full Text] [Related]